Italy approves e-processing of healthcare-related advertising applications
This article was originally published in Clinica
Executive Summary
Italy has approved the use of electronic processing of applications for licences to advertise healthcare products and services. The main benefit of the change will be to hasten the process, according to Dr Romano Marabelli, head of the department of innovation at the general directorate for pharmaceuticals and medical devices (DGFDM). The decision was taken after a three-month trial of the e-processing system, which concluded at the end of December 2010. A statement posted on the health ministry website on 5 January to announce the decision also notes that a number of procedural changes have been made to the system since then.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.